000 | 01462 a2200409 4500 | ||
---|---|---|---|
005 | 20250514011108.0 | ||
264 | 0 | _c20011011 | |
008 | 200110s 0 0 eng d | ||
022 | _a0091-2700 | ||
024 | 7 |
_a10.1177/00912709922007606 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKarara, A H | |
245 | 0 | 0 |
_aThe effect of food on the oral bioavailability and the pharmacodynamic actions of the insulinotropic agent nateglinide in healthy subjects. _h[electronic resource] |
260 |
_bJournal of clinical pharmacology _cFeb 1999 |
||
300 |
_a172-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 |
_aCyclohexanes _xblood |
650 | 0 | 4 |
_aDietary Fats _xpharmacokinetics |
650 | 0 | 4 |
_aFasting _xphysiology |
650 | 0 | 4 | _aFood-Drug Interactions |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xblood |
650 | 0 | 4 |
_aInsulin _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNateglinide |
650 | 0 | 4 |
_aPhenylalanine _xanalogs & derivatives |
700 | 1 | _aDunning, B E | |
700 | 1 | _aMcLeod, J F | |
773 | 0 |
_tJournal of clinical pharmacology _gvol. 39 _gno. 2 _gp. 172-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/00912709922007606 _zAvailable from publisher's website |
999 |
_c11485479 _d11485479 |